Evidence map›Paper›PMID 36291924›Full record

ArticleCancers2022

Defining the Profile of Patients with Primary Merkel Cell Carcinoma in Central Italy: A Retrospective Analysis.

Giulio Gualdi, Gerardo Ferrara, Marco Simonacci, Maria Concetta Fargnoli, Laura Sollima, Elisa Molinelli, Anna Campanati, Giampiero Mazzocchetti, Alfredo Giacchetti, Paolo Amerio and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Giulio GualdiDepartment of Medicine and Aging Science, Dermatologic Clinic, University G. D'Annunzio, Chieti Pescara, 66100 Chieti, Italy.ORCID 0000-0002-1640-6609
Gerardo FerraraAnatomic Pathology and Cytopathology Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', 80131 Naples, Italy.ORCID 0000-0003-0727-4015
Marco SimonacciDepartment of Dermatology, Macerata Hospital, 62100 Macerata, Italy.
Maria Concetta FargnoliDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-7249-2556
Laura SollimaUOC Pathology, Ospedale San Salvatore, 67100 L'Aquila, Italy.
Elisa MolinelliDepartment of Clinical and Molecular Sciences-Dermatological Clinic, Polytechnic Marche University, 60121 Ancona, Italy.
Anna CampanatiDepartment of Clinical and Molecular Sciences-Dermatological Clinic, Polytechnic Marche University, 60121 Ancona, Italy.ORCID 0000-0002-3740-0839
Giampiero MazzocchettiUOSD Dermatologia ASL1 Pescara, 65124 Pescara, Italy.
Alfredo GiacchettiUO Dermatologia, INRCA/IRCCS, 60129 Ancona, Italy.
Paolo AmerioDepartment of Medicine and Aging Science, Dermatologic Clinic, University G. D'Annunzio, Chieti Pescara, 66100 Chieti, Italy.ORCID 0000-0003-1589-9672
On Behalf Of The Study Group
Marche Polytechnic University · ITUniversity of Chieti-Pescara · ITAzienda USL di Pescara · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITOspedale di MacerataSan Salvatore Hospital · ITUniversity of L'Aquila · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Merkel cell carcinoma (MCC) is a rare neuroendocrine skin cancer that usually occurs in elderly people on sun-exposed areas, with a predisposition to local recurrence. Evidence suggests a growing incidence over the past decade; however, robust epidemiologic data are still lacking. We describe the MCC population in clinical practice in a retrospective analysis of demographic, clinical, and tumor characteristics from medical records of primary MCC patients, between 2015 and 2020, at six dermatology clinics in Central Italy. Ninety-four patients were included (57.4% male; mean age 78.2 ± 10.1 years, range 47-99 years). The estimated incidence rate of MCC was 0.93 per 100,000 inhabitants/year. Lower limbs were the most frequently affected site (31.5%), and 54% of patients for whom information was available were immunosuppressed. Lymph node involvement was reported in 42.5% of patients, and distant metastases in almost 20%. Most patients underwent surgery for tumor excision and were mainly referred to specialized dermatology clinics by dermatologists (47.9%) and general surgeons (28.7%). Apart from the relatively balanced prevalence of MCC in men and women, the predominant location on lower limbs, and the higher incidence rate compared with previous reports in Italy, this population is, overall, similar to the populations described in other observational studies. MCC management requires the involvement of several specialties. Increased awareness of MCC and standardization of its management are urgently needed.

Indexed as

dermatologyepidemiologyItalyMerkel Cell Carcinomaobservational studyretrospective analysis

Identifiers

PMID36291924
PMCPMC9600113
OpenAlexW4306938188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.